PhD in Human and Experimental Pathology, working in Molecular Neuroscience. His project focused on investigating pathogenic variants of the SCN2A gene associated with Autism Spectrum Disorder, using hiPSC-derived neuronal models and multiomics approaches. His research integrates strategies for gene modulation, including CRISPRa and cis-regulatory editing, with an emphasis on developing innovative therapies. He is currently working on advancing gene-delivery platforms based on extracellular vesicles, aimed at functional restoration in human neurons.
